Indication: Matulane is indicated for use in combination with other anticancer drugs for the treatment of Stage III and IV Hodgkin’s disease. Matulane is used as part of the MOPP (nitrogen mustard, vincristine, procarbazine, prednisone) regimen.

Important Safety Instruction

Please see full Prescribing Information for Matulane indications and usage, contraindications, and warnings including boxed WARNINGS, precautions, and adverse reactions.

Effective September 6, 2011, Matulane® (procarbazine hydrochloride) capsules (NDC 54482-053-01) will be distributed by Accredo Health Group Inc., a national specialty pharmacy. Click here for information to obtain the product.